Citi lowered the firm’s price target on Clorox (CLX) to $130 from $135 and keeps a Neutral rating on the shares. The firm sees a challenging fundamental backdrop for the beverage and household and personal care group heading into the Q3 reports. It believes trends in the U.S. remain soft.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLX:
- Clorox price target lowered to $125 from $135 at BofA
- Clorox price target lowered to $128 from $134 at UBS
- Clorox price target lowered to $117 from $120 at TD Cowen
- Clorox price target lowered to $112 from $118 at Barclays
- Clorox’s Financial Challenges and Operational Disruptions Lead to Hold Rating